[Sensitivity of the pituitary gland to LH-FSH releasing hormone in women after discontinuation of ovidon, an estrogen-progesterone contraceptive agent].
D000328:Adult; D004997:Ethinyl Estradiol / Q000494:pharmacology*; D019304:Ethinyl Estradiol-Norgestrel Combination; D005260:Female; D005640:Follicle Stimulating Hormone / Q000378:metabolism*; D007987:Gonadotropin-Releasing Hormone; D006728:Hormones; D006801:Humans; D007986:Luteinizing Hormone / Q000378:metabolism*; D009644:Norgestrel / Q000494:pharmacology*; D010903:Pituitary Gland, Anterior / Q000378:metabolism*; D013268:Stimulation, Chemical
D006728:Hormones; D007987:Gonadotropin-Releasing Hormone; D009644:Norgestrel; D004997:Ethinyl Estradiol; D019304:Ethinyl Estradiol-Norgestrel Combination; D007986:Luteinizing Hormone; D005640:Follicle Stimulating Hormone
Chuvstvitel'nost' gipofiza k LG-FSG-rilizing-gormonu u zhenshchin posle otmeny éstrogen-progestagennogo kontratsepnivnogo preparata ovidona.